Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Darcept 40 Injection

Prescription Icon
Prescription Required

Marketer

LG Lifesciences

Salt Composition

Darbepoetin alfa (40mcg)

Overview Darcept 40 Injection

Erythropoiesis-stimulating agent, Darcept 40 Injection, treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under medical supervision, Darcept 40 Injection necessitates cautious use due to potential serious adverse effects. Expert medical guidance is crucial; patients must meticulously follow physician instructions. Common side effects encompass abdominal discomfort, hypertension, skin eruptions, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms indicative of severe hypertension, such as intense headache, visual disturbances, nausea, emesis, or convulsions immediately. Regular blood tests, monitoring electrolyte levels (potassium), hemoglobin, and blood cell counts, will be conducted by your physician. Discontinue use and seek medical attention if shortness of breath or rash develops. Prior to commencing treatment, disclose any history of cardiac disease, hypertension, seizures, or stroke. Pregnant, breastfeeding, or intending to conceive/breastfeed patients should consult their physician regarding the medication's safety profile.

Primary Ingredients of Darcept 40 Injection

No text was provided. Please provide the text you wish me to rephrase.

Uses of Darcept 40 Injection

Managing anemia in patients with chronic kidney disease | Addressing chemotherapy-induced anemia

Major Benefits of Darcept 40 Injection:

Administering this medication will be handled by your physician or their qualified nurse; self-medication is strictly prohibited.

Common Side effects of Darcept 40 Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Darcept 40 Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Darcept 40 Injection works:

Darcept 40 Injection, an erythropoietin-based medication, boosts red blood cell production. This effect is achieved by stimulating the bone marrow's capacity to generate increased numbers of red blood cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Darcept 40 Injection may be unsafe; physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Darcept 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Darcept 40 Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Darcept 40 Injection.

KidneyKidneySAFE IF PRESCRIBED

Darcept 40 Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

For individuals with hepatic impairment, Darcept 40 Injection requires careful administration. Dosage modification of Darcept 40 Injection might be necessary. Physician consultation is advised.

What if you forget to take Darcept 40 Injection :

Should you forget a Darcept 40 Injection dose, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Darcept 40 Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP
Action Class Erythropoietin-stimulating drug

FAQs on Darcept 40 Injection

Expect a rise in your red blood cell count (hemoglobin levels) within 2 to 6 weeks of beginning Darcept 40 Injection. Consult your doctor with any questions.
Darcept 40 Injection requires careful administration due to the potential for serious adverse reactions, including fatalities. Experienced Darcept 40 Injection therapy providers should administer this medication, and all instructions must be followed precisely.
Darcept 40 Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; these should be addressed before treatment. Other factors that can hinder treatment response include bleeding, infections, inflammation, and bone marrow fibrosis. Consult your doctor for further guidance.
Darcept 40 Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults. Consult your doctor for any concerns.
Darcept 40 Injection can influence blood pressure. Monitor blood pressure during initial treatment; patients with hypertension should manage their condition appropriately. Discontinuation of Darcept 40 Injection may be necessary if blood pressure remains uncontrolled.
Darcept 40 Injection should only be used under a doctor's prescription. It is contraindicated for individuals with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by erythropoietin treatment, or a history of serious allergic reactions to this medication.
Darcept 40 Injection
2,030
MRP 2,350
13% off